1887
Preview this article:
Zoom in
Zoomout

Comparison of E test and agar dilution for testing activity of ceftriaxone against , Page 1 of 1

| /docserver/preview/fulltext/jmm/65/7/701_jmm000283-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000283
2016-07-01
2020-01-22
Loading full text...

Full text loading...

/deliver/fulltext/jmm/65/7/701.html?itemId=/content/journal/jmm/10.1099/jmm.0.000283&mimeType=html&fmt=ahah

References

  1. Bala M., Kakran M., Singh V., Sood S., Ramesh V.. Members of the WHO GASP SEAR Network 2013; Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis. Sex Transm Infec89:iv28–iv35 [CrossRef]
    [Google Scholar]
  2. Bell S. M., Pham J. N., Carter I. W., Hanrahan J. K.. 2011; Antibiotic Susceptibility Testing by the CDS Method. A Manual for Medical and Veterinary Laboratories, 6th edn. Randwick, NSW: South Eastern Area Laboratory Services;
    [Google Scholar]
  3. CDC 2015; Sexually transmitted diseases treatment guidelines. MMWR64:1–140
    [Google Scholar]
  4. CLSI 2012; Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Approved Standard, 9th edn, M07-A9 Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  5. Ison C., Hussey J., Sankar K., Evans J., Alexander S.. 2011; Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill 16:19833
    [Google Scholar]
  6. Lahra M. M., Ryder N., Whiley D. M.. 2014; A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia. N Engl J Med371:1850–1851 [CrossRef][PubMed]
    [Google Scholar]
  7. Martin I. M., Hoffmann S., Ison C. A.. ESSTI Network 2006; European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrob Chemother58:587–593 [CrossRef][PubMed]
    [Google Scholar]
  8. Ohnishi M., Golparian D., Shimuta K., Saika T., Hoshina S., Iwasaku K., Nakayama S., Kitawaki J., Unemo M.. 2011; Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother55:3538–3545 [CrossRef]
    [Google Scholar]
  9. Sood S., Mahajan N., Verma R., Kar H. K., Sharma V. K.. 2013; Emergence of decreased susceptibility to extended-spectrum cephalosporins in Neisseria gonorrhoeae in India. Natl Med J India26:26–28[PubMed]
    [Google Scholar]
  10. U.S. Department of Health and Human Services, Food and Drug Administration, and Center for Devices and Radiological Health 2009; Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) System Rockville, MDhttp://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm080564
    [Google Scholar]
  11. Unemo M., Fasth O., Fredlund H., Limnios A., Tapsall J.. 2009; Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother63:1142–1151 [CrossRef][PubMed]
    [Google Scholar]
  12. Unemo M., Golparian D., Syversen G., Vestrheim D. F., Moi H.. 2010; Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill15:19721[PubMed][Crossref]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000283
Loading
/content/journal/jmm/10.1099/jmm.0.000283
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error